We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

11 hedge funds and large institutions have $155K invested in Aethlon Medical in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more capital invested

Capital invested by funds: $45.6K → $155K (+$109K)

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

57% more funds holding

Funds holding: 7 → 11 (+4)

3.35% less ownership

Funds ownership: 6.34% → 2.99% (-3.4%)

Holders
11
Holders Change
+4
Holders Change %
+57.14%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$55.4K
2
SC
Shay Capital
New York
+$32.1K
3
XT
XTX Topco
Cayman Islands
+$30.3K
4
TRCT
Tower Research Capital (TRC)
New York
+$3.66K
5
UBS Group
UBS Group
Switzerland
+$2.04K

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$91
2
Bank of America
Bank of America
North Carolina
-$17

AEMD Hedge Fund Activity: Q1 2026 in Review

11 of the 8,205 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2026, worth a combined $155K — up 240% from $45.6K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new AEMD positions and 2 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $55.4K. The largest seller was Citigroup, exiting entirely with an estimated $91 sold.

  • 11 institutional investors held Aethlon Medical (AEMD) as of Q1 2026, up from 7 in Q4 2025.
  • Funds reported $155K of Aethlon Medical stock for Q1 2026, up 240% quarter-over-quarter.
  • 6 funds opened new Aethlon Medical positions in Q1 2026 and 2 closed out, a net change of +4 holders.
  • The largest Aethlon Medical buyer in Q1 2026 was Geode Capital Management, an estimated $55.4K added.
  • The largest Aethlon Medical seller in Q1 2026 was Citigroup, an estimated $91 sold.

Based on aggregated 13F filings for Q1 2026.